NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University of Milan
Conditions: Coronavirus Infections, Respiratory Failure, Ventilator Lung
Interventions: standard operating procedures
Countries: Italy
In December 2019 a new kind of virus was identified in China as the responsible of severe acute respiratory syndrome (SARS) and interstitial pneumonia. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) quickly spread around the world and in February 2020 became a pandemia in Europe. No pharmacological treatment is actually licensed for the SARS-CoV2 infection and at the current state of art there is a lack of data about the clinical management of the coronavirus 2019 disease (COVID-19). The aim of this observational study is to collect the data and the outcomes of COVID-19 patients admitted in the H. Sacco Respiratory Unit treated according to the Standard Operating Procedures and the Good Clinical Practice.
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Patients that can give written or oral informed consent * patients with microbiological diagnosis (i.e. rhinopharyngeal swab) of SARS-CoV2 infection Exclusion Criteria: * severe cognitive impairment * absolute contraindication to non invasive ventilation or cpap therapy * rhinopharyngeal swab negative for SARS-CoV2
- Milan, Lombardy, Italy